Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Röhm is a global leader in methacrylate chemicals and a key supplier of high-performance materials to the healthcare and medical device industries. The company is widely recognized for its CYROLITE® brand, a range of transparent, acrylic-based copolymers specifically engineered for medical applications such as IV sets, blood filters, and diagnostic disposables. These materials are valued for their exceptional clarity, lipid resistance, and compatibility with various sterilization methods. While the company's historical pharmaceutical excipients business (Eudragit) remains with Evonik, Röhm continues to provide essential polymer solutions for drug delivery systems and laboratory equipment. Following its 2019 carve-out from Evonik Industries, Röhm operates as an independent company owned by Advent International, maintaining a robust global manufacturing and R&D footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ROHM.